NCT04575259 - OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001 | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

May 31, 2022

Study Completion Date

June 30, 2022

Conditions

Parkinson Disease Dementia

Interventions

DRUG

ANAVEX2-73

Oral capsules

Trial Locations (10)

KaRa MINDS, Macquarie Park

Hammond Care, Malvern

Hospital Mutua Terrasa, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

Hospital del Henares, Coslada

Clínica Universidad de Navarra (CUN) - Sede Madrid- Servicio de Neurología -, Madrid

Hospital Clínico San Carlos, Madrid

Hospital Universitario Puerta de Hierro, Madrid

Hospital Universitario Central de Asturias (HUCA), Oviedo

Hospital Universitario Virgen del Rocío, Seville